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Introduction: In healthy subjects, Cytomegalovirus infection can be asymptomatic or manifest as mononucleosis
syndrome, but organ disease has also been reported. However, in immunocompromised patients this infection can
lead to its most significant and severe disease and even mortality. When Cytomegalovirus causes a gastrointestinal
tract infection, it more commonly manifests with luminal tract disease and is usually characterized by ulcerative lesions.
Appendicitis is a rare manifestation, and has been reported mainly in human immunodeficiency virus-infected patients
or patients with other causes of immunocompromise.
Case presentation: The authors report on a case of acute primary Cytomegalovirus infection complicated with acute
appendicitis due to Cytomegalovirus in an apparently immunocompetent 24-year-old Caucasian man also suffering from
primary sclerosing cholangitis and ulcerative colitis. Diagnosis was based on clinical manifestations, serology results, as
well as microbiological and histological findings. Treatment consisted of surgery and anti-Cytomegalovirus therapy.
Conclusions: Cytomegalovirus should be included among the etiologic agents of acute appendicitis in patients with
primary sclerosing cholangitis and ulcerative colitis. Currently, there are no definitive data regarding the frequency of
Cytomegalovirus appendicitis and the role of anti-Cytomegalovirus treatment in human immunodeficiency virus-negative
and apparently immunocompetent subjects.
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Ulcerative colitisIntroduction
In healthy subjects, Cytomegalovirus (CMV) infection
can be asymptomatic or manifest as mononucleosis
syndrome, but organ disease has also been observed
[1-3]. However, in immunocompromised patients, CMV
infection can lead to its most significant and severe
disease manifestations. In bone marrow recipients, CMV
pneumonia is the most common life-threatening infec-
tion after transplantation [1]. CMV infection is the most
common viral infection in patients with human im-
munodeficiency virus (HIV) infection and CMV retinitis* Correspondence: mariabruna.pasticci@unipg.it
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reproduction in any medium, provided the orcontinues to be the most frequent sight-threatening
infection in the era of highly active antiviral therapy [1].
In patients with HIV infection, CMV disease of the
gastrointestinal tract is also frequently observed [1,2].
CMV infection of the gastrointestinal tract can occur
anywhere in the gastrointestinal system but luminal tract
disease is the most common localization and is usually
characterized by ulcerative lesions. Esophagitis and col-
itis are the most frequent manifestations; however, CMV
gastritis, small bowel enteritis, intestinal stricture, procti-
tis, cholangitis, hepatitis and pancreatitis have been ob-
served [1-3]. CMV appendicitis is a rare manifestation,
reported mainly in HIV infected patients [4,5]. Less
frequently involved are patients with other causes of
immunocompromise [6-8] and very few cases have beenLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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However, Dzabic et al. have evidenced cells which were
double positive for both early CMV antigens and interleu-
kin (IL)-6 and/or IL-8 in 63% of patients with confirmed
acute appendicitis and have found a possible correlation
with CMV infection and the severity of disease [11]. CMV
was also the most frequently detected virus in a study in-
cluding 38 children who had undergone appendectomy
for acute appendicitis [12].
The authors report a case of acute primary
Cytomegalovirus infection complicated with acute ap-
pendicitis due to Cytomegalovirus in an apparently
immunocompetent patient also suffering from primary
sclerosing cholangitis (PSC) and ulcerative colitis (UC).
Case presentation
A 24-year-old Caucasian man with fever and upper
quadrant abdominal pain over the previous 20 days was
admitted to our hospital. Before admission, ciprofloxacin
and metronidazole, followed by cefixime had been pre-
scribed. Six years prior, the patient had been diagnosed
with PSC, UC, suspected retroperitoneal fibrosis, bile
sludge and splenomegaly. For this, he was prescribed
ursodiol 300mg BID and mesalamine 4g per day. At that
time, investigations included exploratory laparotomy and
a biopsy of the perihepatic, retroperitoneal tissue which
excluded malignancy. Over this six-year period, the
patient presented with recurrent episodes of cholangitis,
the serum level of aminotransferases remained substan-
tially normal while there was a progressive worsening of
cholestatic test results and a progressive liver enlarge-
ment along with fibrosis. Specifically, gamma glutamyl
transpeptidase (GGT) and alkaline phosphatase (ALP)
increased from 141UI/L to 344UI/L and 847UI/L to
2534UI/L, respectively. Hepatic tissue stiffness, mea-
sured by FibroScan®, progressed from 12.6 to 17.3kPa.Figure 1 Magnetic resonance showing bile duct irregularities (a); T2-w
enhancement (b).The patient was never treated with immunosuppressive
therapy or corticosteroids. One month before admission,
an upper endoscopy was performed which excluded
esophageal varices. One week before admission, a mag-
netic resonance of his abdomen and bile ducts revealed
further enlargement of the liver, spleen and the tissue
surrounding his hepatic hilum (Figure 1a), posterior to
the pancreas head. The latter caused a compression of
his second duodenal tract and a wrapping of the splenic
and hepatic arteries. Beading and narrowing of the intra-
hepatic and common bile ducts (Figure 1b) resulted in
more extension and a narrowing of the pancreatic duct
was also reported.
At admission, our patient had a fever of 38.8°C and
physical examination revealed tenderness of his epigas-
trium and right upper hypochondrium. Results from
blood tests are reported in Table 1. Microbiological
blood and urine investigations were negative for bacteria.
A chest radiograph was normal while an abdominal
sonography revealed an enlarged liver, thickened chole-
docus, dilatation of the intra-hepatic biliary tree, spleno-
megaly and lymphadenopathy of the hepatic hilus. A
colonoscopy showed erythema of the colonic mucosa
from the rectum to the cecum, with areas of increased
erythema and telangiectasia in the ascending colon. Ran-
dom biopsy showed focal atrophy of the colonic mucosa
with edema and chronic inflammatory infiltrates, but
specific investigations for CMV were not carried out.
Imipenem 500mg IV four times daily was administered.
Three days later, due to our patient’s persisting fever and
abdominal pain, imipenem was substituted with tigecyc-
line 50mg IV BID. Further blood and urine cultures for
bacteria were negative. Both the erythrocyte sedimentation
rate (ESR) and C-reactive protein level (C-RP) remained
high, whereas the white blood cell (WBC) and neutrophil
counts decreased (Table 1) and the procalcitonin leveleighted image, depicting hepatic hilum tissue with contrast
Table 1 Laboratory tests
2/22/2012 3/3/2012 3/6/2012 3/7/2012 3/19/2012 04/11/2012
WBCs (3.60 to 9.60 × 103μL) 14.45 8.19 9.02 8.6 9.43 8.7
Neutrophils (42.0 to 75.0%) 80.9 34.0 38.0 48 62 69.3
Lymphocytes (20.5 to 51.1%) 11.7 57.0 52.8 43 30 19
Monocytes (1.0 to 10.0%) 6.6 5.0 5.3 8 6 9
Eosinophils (≤5%) 0.5 0.0 0.7 0 2 2.2
Basophils (≤1%) 0.3 3.0 3.2 1 0 0.5
CD4 + T (430 to 1590mm3, 30 to 70%) 1055 (20.3%) 1132 (41%)
CD8 + T (220 to 1040mm3, 13 to 40%) 3193 (67%) 849 (31%)
Hb (13.0 to 17.0g/dL) 12.3 10.9 9.9 9.9 10.2 10.5
RBCs (4.30 to 5.80 × 106μL) 4.26 3.93 3.54 3.58 3.55 3.74
I.N.R (0.80 to 1.2) 1.40 1.4 1.2
PLT (140 to 440 × 103μL) 374 215 383 355
Albumin (3.5 to 4.5g/dL) 4.2 3.9
ALT (0 to 45UI/L) 56 35 36 20 16 65
AST (0 to 45UI/L) 66 65 70 34 36 58
GGT (7 to 49UI/L) 344 197 197 181 266 277
ALP (80 to 320UI/L) 2534 1819 1671 1360 1652 -
TB (0.00 to 1.20mg/dL) 1.91 1.2 1.69 1.2 1.27 1.44
DB (0.00 to 0.25mg/dL) 1.37 0.79 1.18 0.86 0.88 1.0
Amylase (30 to 118) UI/L 44 47
Immunoglobuline IgG (650 to 1600mg/dL) 3360
IgG4 (110 to 1570mg/dL) 521
Azotemia (10 to 50mg/dL) 22 14
Creatinine (0.50 to 1.40mg/dL) 0.68 0.5
ESR (1 to 25 1°h) 104 81 120 99 120 120
C-RP (0.0 to 0.5mg/dL) 4.8 2.8 7.7 5.4 1.6
CMV-IgG (<20U/mL neg) 11.4 79 65
CMV-IgM (<20U/mL neg) 11.2 69 43
CMV-Avidity Index <0.5 low 0.2 0.1
Blood CMV-PCR (copies/mL) <253 6189
Urine CMV-PCR (copies/mL) 1431
Appendix CMV-PCR *(copies/mL) 1210
Appendix culture Positive
Appendix immunohistochemistry Positive
ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; C-RP, C Reactive Protein; DB, direct bilirubin; ESR, erythrocyte sedimentation
rate; GGT, gamma-glutamyl transpeptidase; I.N.R, international normalized ratio; PLT, platelets; RBCs, red blood cells; TB, total bilirubin; WBCs, white blood cells.
*DNA-CMV was quantified (Q-CMV Real Time, Nanogen Advanced Diagnostics, Torino, Italy) after tissue digestion for 30 minutes at 56°C with proteinase K buffer
500μL (Diatech Laboratories, Jesi, Italy) and DNA extraction with EasyMAG (bioMerieux, Merci L’Etoile, France), following the manufacturers’ instructions.
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abdominal pain subsided slightly. Investigations for
HIV, Toxoplasma gondii, CMV, measles, parotitis and
hepatitis C virus (HCV) all were negative, while results
for varicella zoster virus, human herpes virus, Epstein
Barr, rubella, and parvo virus B19 indicated previous
infection. CD4 + T lymphocytes were 1055mm3 (20.3%)
and CD3 + T lymphocytes were 3193mm3 (67%).Mycobacterium tuberculosis interferon gamma release
assay (QuantiFERON®–TB Gold, Cellestis Limited, Carne-
gie, Victoria, Australia) showed negative results. Twelve
days after admission, teicoplanin 400mg die, gentamicin
80mg TID, metronidazole 500mg TID were prescribed,
while tigecycline was stopped. Two days later, deoxyribo-
nucleic acid (DNA) Cytomegalovirus (Q-CMV Real
Time, Nanogen Advanced Diagnostics, Torino, Italy)
Figure 2 Acute catarrhal appendicitis (a); abdominal ultrasound showing “finger in glove” anechoic image with incompressible lumen (b).
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days later, this value increased to 6189 copies/mL,
while 1431 copies/mL were evidenced from a urine
sample, the CMV pp65-antigen (Indirect Immunofluores-
cence, anti-CMV pp-UL83, Argene, France) was also
positive, and CMV serology indicated acute CMV
infection (Table 1). Our patient’s fever rose to 39.2°C
and his abdominal pain extended to the right lower
abdominal quadrant with radiation to the right groin
and right testicle. Ultrasound (Figure 2a) suggested
acute appendicitis and he underwent surgery (Figure 2b).
Histology showed inflammatory infiltrates, including
lymphocytes and neutrophils, while histochemistry was
positive for CMV early antigens (Monoclonal Mouse
Anti-Cytomegalovirus Clone CCH2 + DDG9, Ventana
Medical System, Roche, USA) (Figure 3). Real time
reaction and shell vial culture of the appendix tissue
also were positive. Microbiological investigations for
bacteria and fungi showed Peptococcus spp. and Candida
albicans. Teicoplanin, gentamicin and metronidazole were
administered for a total of 12 days along with intravenousFigure 3 Appendix section: early Cytomegalovirus antigens
(Monoclonal Mouse Anti-Cytomegalovirus Clone CCH2 + DDG9,
Ventana Medical System, Roche, USA).ganciclovir 5mg/kg twice for 15 days. After discharge, oral
valganciclovir 900mg BID was prescribed for 10 days.
After this, the CMV nucleic acid in the blood and urine
was negative while ESR and cholestatic liver test results
remained abnormally high (Table 1).
Discussion
Primary sclerosing cholangitis is a disease of the bile
ducts that causes inflammation and subsequent obstruc-
tion of the intra-hepatic and extra-hepatic bile ducts.
Over time, the inflamed ducts develop scar tissue and
this disrupts bile flow [13]. In addition to bile duct dis-
ease, 60 to 80% of patients with PSC have inflammatory
bowel disease, typically ulcerative colitis [13]. Patients
with PSC-UC may have a different phenotype compared
to classic UC. Despite minimal endoscopic activity,
these patients have more extensive colon involvement,
more active histology inflammation and an increased
risk of colorectal cancer [13,14]. An inverse prognostic
relationship between PSC and UC has also been
observed and progressive PSC requiring a liver trans-
plant seems to be associated with UC, that is less
symptomatic and less often requires colectomy [13].
Florin et al. investigated for an interaction between ap-
pendectomy and PSC in the epidemiology and clinical
behavior of PSC-UC, finding no lower rates of append-
ectomy in PSC patients. However, prior appendectomy
appeared to be associated with approximately a five-year
delay in the onset of intestinal or hepatic disease [15]. A
subgroup of patients with PSC having an overlap syn-
drome characterized by lymphoplasmacytic infiltrates,
rich in IgG4-positive cells, has been identified [13,16].
Similar to classic PSC, these patients may have other
autoimmune disorders, including autoimmune pancrea-
titis, autoimmune hepatitis, inflammatory bowel diseases,
Sjögren's syndrome, nephritis and retroperitoneal fibro-
sis [13,16,17]. This immunoglobulin overlapping syn-
drome has been reported to be ameliorated with
corticosteroid therapy [13,16]. Regarding our case re-
port, the normal value of IgG4 excluded a diagnosis of
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the retroperitoneal fibrosis had a mild clinical progressive
behavior. For these reasons, our patient was never treated
with corticosteriods or immunosuppressive therapy.
CMV has also been implicated as a possible etiology in
sclerosing cholangitis-like syndrome in patients with
HIV infection [1,18]. CMV infection was not the cause
of liver and bile duct disease in our patient. Also, clinical
laboratory and endoscopic findings did not indicate
CMV colitis [1,2,19]. In fact, typical CMV endoscopic
findings were not detected, while CMV antibodies and
CMV antigens were positive only 10 days after our pa-
tient was admitted.
At admission, our patient presented with right upper
abdominal pain, elevated leucocyte and neutrophil counts,
increased bilirubin, GGTand ALP levels. Therefore, recur-
rent bacterial cholangitis was the admitting diagnosis.
However, despite an initial improvement with the admin-
istration of antimicrobials, his condition worsened due to
increased fever and abdominal pain, also involving, at that
time, the right lower abdominal quadrant, right groin and
testicle. Acute appendicitis was diagnosed based on the
clinical and ultrasound findings. Simultaneously, labora-
tory results indicated acute CMV infection; acute appendi-
citis due to CMV complicating acute CMV infection was
suspected. Anti-CMV treatment was added to antimi-
crobials and our patient underwent surgery.
In our patient, CMV acute infection and acute CMV
appendicitis were diagnosed based on: 1) CMV serology;
2) CMV DNA in the blood; 3) peripheral blood lympho-
cytosis; 4) the presence of CMV early antigen with im-
munohistochemistry in the appendix; 5) evidence from
the literature that CMV gastrointestinal diseases, includ-
ing florid appendicitis, can also occur in patients appar-
ently non-immunocompromised [2,3,8-12]. Our patient
was HIV negative and was never treated with immuno-
suppressive drugs; however, it is plausible that the chronic
inflammatory state involving the intra-hepatic and com-
mon bile ducts and the colon or the primary CMV in-
fection itself induced a temporary moderate lowering of
CD4+ T lymphocytes causing a change in the immune
reactivity favoring CMV organ disease [2,3,20]. The ab-
sence of intra-nuclear “owl’s eye” in the histology cannot
exclude the diagnosis, given that this specific histological
finding has a lower sensitivity than immunohistochemistry
and molecular diagnostic methods [21].
Conclusions
CMV should be included among the etiologic agents of
acute appendicitis in patients with primary sclerosing
cholangitis and ulcerative colitis. Currently, there are no
definitive data regarding the frequency of CMV appendi-
citis and the role of anti-CMV treatment in HIV nega-
tive and apparently immunocompetent subjects.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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